Related references
Note: Only part of the references are listed.Chemoprevention of colorectal cancer: systematic review and economic evaluation
K Cooper et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention
Leticia Moreira et al.
CURRENT DRUG TARGETS (2011)
Supplemental Calcium in the Chemoprevention of Colorectal Cancer: A Systematic Review and Meta-Analysis
Christopher Carroll et al.
CLINICAL THERAPEUTICS (2010)
NSAIDs and the colon
Angel Lanas et al.
CURRENT OPINION IN GASTROENTEROLOGY (2009)
Use of nonsteroidal Antiinflammatory drugs an update for clinicians - A scientific statement from the American Heart Association
Elliott M. Antman et al.
CIRCULATION (2007)
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: A systematic review prepared for the US Preventive Services Task Force
Alaa Rostom et al.
ANNALS OF INTERNAL MEDICINE (2007)
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas
John A. Baron et al.
GASTROENTEROLOGY (2006)
Celecoxib for the prevention of colorectal adenomatous polyps
Nadir Arber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Celecoxib for the prevention of sporadic colorectal adenomas
Monica M. Bertagnolli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
COX-2: A molecular target for colorectal cancer prevention
JR Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database
MJS Langman et al.
BRITISH MEDICAL JOURNAL (2000)